Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Metformin
Related studies linked through entity extraction aliases.
12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE2
Insulin Glargine Combination Therapies in Type II Diabetics
- Status
- COMPLETED
- Phase
- PHASE3
Response To Oral Agents in Diabetes (ROAD)- Pilot Study
- Status
- COMPLETED
- Phase
- PHASE4
Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study
- Status
- WITHDRAWN
- Phase
- PHASE4
Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE2
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
- Status
- COMPLETED
- Phase
- PHASE3
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.
- Status
- TERMINATED
- Phase
- PHASE3
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
- Status
- COMPLETED
- Phase
- PHASE3
Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes
- Status
- WITHDRAWN
- Phase
- PHASE3
Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients
- Status
- COMPLETED
- Phase
- PHASE4
Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide
- Status
- COMPLETED
- Phase
- N/A
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
- Status
- COMPLETED
- Phase
- PHASE3